Weili joined M Ventures as a fellow in September 2020. Before joining M Ventures, Weili worked with Australia China Innovation Centre (ACIC) on technology commercialization and investment advisory in Australia, and KPMG on digital innovation consultancy. He is currently an external advisor for a Shenzhen (China) based equity fund on pharmaceutical equity research. Weili holds a Master’s degree in Molecular Biology and is currently at final stage of his PhD waiting for conferral at The University of Queensland. During his PhD, Weili completed CFA level I and obtained a second Master’s Degree in Technology and Innovation Management at The University of Queensland, with working experience at UniQuest on biotechnology commercialization. Weili is based in Amsterdam.